Tamiflu is the major antiviral drug in countries stockpiles, but reports of Tamiflu resistance damage the long-term usefullness of this drug. The current alternative Relenza does not suffer from adverse reistance - so, of course sales of Relenza are going to increase. Japan and UK made the adjustments in their stockpiles already. Canada and Us are preparing to...
